The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
Open accessAbstract
Background: Cancer therapy–induced cardiomyopathy (CCM) is associated with cumulative drug exposures and preexisting cardiovascular disorders. These parameters incompletely account for substantial interindividual susceptibility to CCM. We hypothesized that rare variants in cardiomyopathy genes contribute to CCM. Methods: We studied 213 patients with CCM from 3 cohorts: retrospectively recruited adults with diverse cancers (n=99), prospectively phenotyped adults with breast cancer (n=73), and prospectively phenotyped children with acute myeloid leukemia (n=41). Cardiomyopathy genes, including 9 prespecified genes, were sequenced. The prevalence of rare variants was compared between CCM cohorts and The Cancer Genome Atlas participants (n=2053), healthy volunteers (n=445), and an ancestry-matched reference population. Clinical characteristics and outcomes were assessed and stratified by genotypes. A prevalent CCM genotype was modeled in anthracycline-treated mice. Results: CCM was diagnosed 0.4 to 9 years after chemotherapy; 90% of these patients received anthracyclines. Adult patients with CCM had cardiovascular risk factors similar to the US population. Among 9 prioritized genes, patients with CCM had more rare protein-altering variants than comparative cohorts ( P ≤1.98e–04). Titin-truncating variants (TTNtvs) predominated, occurring in 7.5% of patients with CCM versus 1.1% of The Cancer Genome Atlas participants ( P =7.36e–08), 0.7% of healthy volunteers ( P =3.42e–06), and 0.6% of the reference population ( P =5.87e–14). Adult patients who had CCM with TTNtvs experienced more heart failure and atrial fibrillation ( P =0.003) and impaired myocardial recovery ( P =0.03) than those without. Consistent with human data, anthracycline-treated TTNtv mice and isolated TTNtv cardiomyocytes showed sustained contractile dysfunction unlike wild-type ( P =0.0004 and P <0.002, respectively). Conclusions: Unrecognized rare variants in cardiomyopathy-associated genes, particularly TTNtvs, increased the risk for CCM in children and adults, and adverse cardiac events in adults. Genotype, along with cumulative chemotherapy dosage and traditional cardiovascular risk factors, improves the identification of patients who have cancer at highest risk for CCM. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifiers: NCT01173341; AAML1031; NCT01371981.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Self-citationSwain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Self-citationEarly Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Self-citationArmenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Self-citationPlana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu192 · Cited by 1,058
Self-citationCurigliano, G., Cardinale, D., Suter, T., Plataniotis, G., de Azambuja, E., Sandri, M. T., Criscitiello, C., Goldhirsch, A., Cipolla, C., & Roila, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds293 · Cited by 865
Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., Cohen, V., Banchs, J., Carver, J. R., Wiegers, S. E., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.973321 · Cited by 814
Self-citationWalsh, R., Thomson, K. L., Ware, J. S., Funke, B. H., Woodley, J., McGuire, K. J., Mazzarotto, F., Blair, E., Seller, A., Taylor, J. C., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.90 · Cited by 734
Self-citationShared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
Ware, J. S., Li, J., Mazaika, E., Yasso, C. M., DeSouza, T., Cappola, T. P., Tsai, E. J., Hilfiker-Kleiner, D., Kamiya, C. A., Mazzarotto, F., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505517 · Cited by 613
Self-citationArmenian, S. H., Xu, L., Ky, B., Sun, C., Farol, L. T., Pal, S. K., Douglas, P. S., Bhatia, S., & Chao, C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0409 · Cited by 559
Self-citationAtlas of the clinical genetics of human dilated cardiomyopathy
Haas, J., Frese, K. S., Peil, B., Kloos, W., Keller, A., Nietsch, R., Feng, Z., Müller, S., Kayvanpour, E., Vogel, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu301 · Cited by 557
Roberts, A. M., Ware, J. S., Herman, D. S., Schafer, S., Baksi, J., Bick, A. G., Buchan, R. J., Walsh, R., John, S., Wilkinson, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010134 · Cited by 491
Self-citationWojnowski, L., Kulle, B., Schirmer, M., Schlüter, G., Schmidt, A., Rosenberger, A., Vonhof, S., Bickeböller, H., Toliat, M. R., Suk, E.-K., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.576850 · Cited by 489
Titin-truncating variants affect heart function in disease cohorts and the general population
Schafer, S., de Marvao, A., Adami, E., Fiedler, L. R., Ng, B., Khin, E., Rackham, O. J. L., van Heesch, S., Pua, C. J., Kui, M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3719 · Cited by 362
Self-citationMoreira, E. S., Wiltshire, T. J., Faulkner, G., Nilforoushan, A., Vainzof, M., Suzuki, O. T., Valle, G., Reeves, R., Zatz, M., Passos-Bueno, M. R., et al. (2000) · Nature Genetics · doi:10.1038/72822 · Cited by 337
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy
Burke, M. A., Cook, S. A., Seidman, J. G., & Seidman, C. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.079 · Cited by 325
Self-citationGenetic Etiology for Alcohol-Induced Cardiac Toxicity
Ware, J. S., Amor-Salamanca, A., Tayal, U., Govind, R., Serrano, I., Salazar-Mendiguchía, J., García-Pinilla, J. M., Pascual-Figal, D. A., Nuñez, J., Guzzo-Merello, G., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.462 · Cited by 310
Self-citationTcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.058 · Cited by 302
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
Hahn, V. S., Lenihan, D. J., & Ky, B. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000665 · Cited by 264
Self-citationVisscher, H., Ross, C. J. D., Rassekh, S. R., Sandor, G. S. S., Caron, H. N., van Dalen, E. C., Kremer, L. C., van der Pal, H. J., Rogers, P. C., Rieder, M. J., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24505 · Cited by 204
Genetics and genomics of dilated cardiomyopathy and systolic heart failure
Tayal, U., Prasad, S. K., & Cook, S. A. (2017) · Genome Medicine · doi:10.1186/s13073-017-0410-8 · Cited by 181
Self-citationNarayan, H. K., Finkelman, B., French, B., Plappert, T., Hyman, D., Smith, A. M., Margulies, K. B., & Ky, B. (2017) · Circulation · doi:10.1161/circulationaha.116.023463 · Cited by 173
Self-citationChopra, A., Kutys, M. L., Zhang, K., Polacheck, W. J., Sheng, C. C., Luu, R. J., Eyckmans, J., Hinson, J. T., Seidman, J. G., Seidman, C. E., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2017.12.012 · Cited by 169
Self-citationAnthracycline-induced cardiomyopathy
KEEFE, D. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90193-9 · Cited by 169
Wang, X., Liu, W., Sun, C.-L., Armenian, S. H., Hakonarson, H., Hageman, L., Ding, Y., Landier, W., Blanco, J. G., Chen, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.3557 · Cited by 161
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity
Christenson, E. S., James, T., Agrawal, V., & Park, B. H. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.10.013 · Cited by 141
Rasmussen, M. L., Taneja, N., Neininger, A. C., Wang, L., Robertson, G. L., Riffle, S., Shi, L., Knollmann, B. C., Burnette, D. T., & Gama, V. (2019) · iScience · doi:10.1016/j.isci.2020.101015 · Cited by 98
Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation
Cuenca, S., Caño, M. J., Gimeno, J. R., Jurado, A., Salas, C., Gomez-Diaz, I., Padrón-Barthe, L., Grillo, J. J., Vilches, C., Segovia, J., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.12.014 · Cited by 82
Self-citationTruncating Titin ( TTN) Variants in Chemotherapy-Induced Cardiomyopathy
Linschoten, M., Teske, A. J., Baas, A. F., Vink, A., Dooijes, D., Baars, H. F., & Asselbergs, F. W. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.03.003 · Cited by 81
The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology
Fatunde, O. A., & Brown, S.-A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020604 · Cited by 77
Tayal, U., Newsome, S., Buchan, R. J., Whiffin, N., Walsh, R., Barton, P. J. R., Ware, J. S., Cook, S. A., & Prasad, S. K. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.530 · Cited by 75
Self-citationWells, Q. S., Veatch, O. J., Fessel, J. P., Joon, A. Y., Levinson, R. T., Mosley, J. D., Held, E., Lindsay, C. S., Shaffer, C. M., Weeke, P., et al. (2017) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000284 · Cited by 59
Self-citationGenetics in Dilated Cardiomyopathy
García‐Pavía, P., Marcos, M. C., Guzzo-Merello, G., Gómez-Bueno, M. F., Bornstein, B., Lara‐Pezzi, E., Segovia, J., & Alonso‐Pulpón, L. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.77 · Cited by 51
Self-citationWasielewski, M., van Spaendonck‐Zwarts, K. Y., Westerink, N.-D. L., Jongbloed, J. D. H., Postma, A., Gietema, J. A., van Tintelen, J. P., & van den Berg, M. P. (2014) · Open Heart · doi:10.1136/openhrt-2014-000116 · Cited by 51
Prevention of Chemotherapy Induced Cardiomyopathy
Payne, D., & Nohria, A. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0353-9 · Cited by 44
The year in cardiology: heart failure
Cleland, J. G. F., Lyon, A. R., McDonagh, T. A., & McMurray, J. J. V. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz949 · Cited by 37
Self-citationSecond Hits in Dilated Cardiomyopathy
Marstrand, P., Picard, K., & Lakdawala, N. K. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-1260-3 · Cited by 31
Titin truncating mutations: A rare cause of dilated cardiomyopathy in the young
Fatkin, D., Lam, L., Herman, D. S., Benson, C. C., Felkin, L. E., Barton, P. J. R., Walsh, R., Candan, Ş., Ware, J. S., Roberts, A. M., et al. (2016) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2016.01.003 · Cited by 26
Self-citationCardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts
Biasillo, G., Cipolla, C. M., & Cardinale, D. M. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0610-9 · Cited by 25
The First Titin (c.59926 + 1G > A) Founder Mutation Associated with Dilated Cardiomyopathy
Hoorntje, E. T., van Spaendonck‐Zwarts, K. Y., Rijdt, W. P. T., Boven, L. G., Vink, A., van der Smagt, J. J., Asselbergs, F. W., van Wijngaarden, J., Hennekam, E. A. M., Pinto, Y. M., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1030 · Cited by 20
Cited by
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Self-citation2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Self-citationDavis, M. B., Arany, Z., McNamara, D. M., Goland, S., & Elkayam, U. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.014 · Cited by 527
Self-citationLyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac106 · Cited by 507
Self-citationWilde, A. A. M., Semsarian, C., Márquez, M. F., Shamloo, A. S., Ackerman, M. J., Ashley, E. A., Sternick, E. B., Barajas-Martinez, H., Behr, E. R., Bezzina, C. R., et al. (2022) · Europace · doi:10.1093/europace/euac030 · Cited by 380
Self-citation
Metadata
- Authors
- Garcia-Pavia, P., Kim, Y., Restrepo-Cordoba, M. A., Lunde, I. G., Wakimoto, H., Smith, A. M., Toepfer, C. N., Getz, K., Gorham, J., Patel, P., Ito, K., Willcox, J. A., Arany, Z., Li, J., Owens, A. T., Govind, R., Nuñez, B., Mazaika, E., Bayes-Genis, A., Walsh, R., Finkelman, B., Lupon, J., Whiffin, N., Serrano, I., Midwinter, W., Wilk, A., Bardaji, A., Ingold, N., Buchan, R., Tayal, U., Pascual-Figal, D. A., de Marvao, A., Ahmad, M., Garcia-Pinilla, J. M., Pantazis, A., Dominguez, F., John Baksi, A., O’Regan, D. P., Rosen, S. D., Prasad, S. K., Lara-Pezzi, E., Provencio, M., Lyon, A. R., Alonso-Pulpon, L., Cook, S. A., DePalma, S. R., Barton, P. J. R., Aplenc, R., Seidman, J. G., Ky, B., Ware, J. S., & Seidman, C. E.
- Venue
- Circulation
- Published
- 2019-07-02
- Volume
- 140
- Issue
- 1
- Pages
- 31-41
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2938273454
- Cited by
- 357
- References
- 44
- FWCI
- 25.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.